Initiative for innovative companies in Basel-Landschaft
A new initiative has been launched to support innovative SMEs and startups in the canton of Basel-Landschaft in an effort to make the region even more attractive and strengthen its ability to innovate. The initiative will offer both financial assistance and advisory services.
Entrepreneur with ideas (Img: Ollyy/shutterstock)
The “100 fürs Baselbiet” (100 for Basel-Landschaft) initiative is aimed at established SMEs or startups connected to the canton of Basel-Landschaft. Launched by the Basellandschaftliche Kantonalbank (BLKB), the University of Applied Sciences Northwestern Switzerland (FHNW) and the economic development agency of Baselland, the initiative aims to enable “100 companies with current or future value creation in the canton to take a decisive step forward in their development”. It will combine access to financial resources with advisory services.
“The initiative is an example of how we at BLKB understand sustainability and planning for the future,” said Beat Röthlisberger, head of corporate customary advisory services at BLKB. “We are breaking new ground in corporate financing to complement traditional lending, and we are addressing target groups beyond our core business.”
Companies that are interested in receiving support through the initiative can now apply online. Candidates will undergo a two-stage selection process, before a final decision is made by an advisory board. Successful applicants will receive a loan of between CHF 100,000 and CHF 500,000 at an “attractive interest rate depending on the risk” with a three-year term. During those three years, the companies will also receive advisory services from an initiative mentor and have access to the networks of BLKB and the economic development agency of Baselland.
Share this article
You may also be interested in
The Japanese conglomerate Yokogawa has established a Swiss subsidiary based at the Switzerland Innovation Park Basel Area. Here, the focus will be on driving forward innovation in the field of biotechnology.Read More
The Werner Siemens Foundation is to invest an additional 12 million Swiss francs in the Miracle project. Researchers at the University of Basel are developing visionary technology for the use of robots in surgery within the framework of this project.Read More
The Basel-based biopharmaceutical company Versameb has successfully closed a seed financing round. Versameb develops therapies on the basis of mRNA sequences and is now seeking to drive forward the clinical development of its platform devised for this.Read More